Literature DB >> 11866874

Inhibitory effect and mechanism of action of sanggenon C on human polymorphonuclear leukocyte adhesion to human synovial cells.

Liang-Cheng Li1, Fang Shen, Qi Hou, Gui-Fang Cheng.   

Abstract

AIM: To examine the effect of sanggenon C on human polymorphonuclear leukocyte (PMN) adhesion to human synovial cell(HSC), and explore its mechanism.
METHODS: Adhesion of PMN to HSC was measured by MTT colorimetry. Cell-ELISA and RT-PCR methods were used to examine the expression of adhesion molecules ICAM-1 and VCAM-1. Activation of nuclear factor-kappa B(NF-kappaB) was measured by electrophoretic mobility shift assays(EMSA) method.
RESULTS: Sanggenon C effectively inhibited TNF-alpha (50 kU/L for 12 h) and IL-1beta (50 kU/L for 12 h) induced adhesion of PMN to HSC (IC50 27.29 nmol/L and 54.45 nmol/L, respectively) in a concentration-dependent manner. Adhesion molecule VCAM-1 surface protein and mRNA expression induced by TNF-alpha 50 kU/L were significantly inhibited by sanggenon C, nevertheless, for ICAM-1 only surface protein expression being inhibited. The activation of NF-kappaB was also extensively inhibited by sanggenon C.
CONCLUSION: Sanggenon C inhibited TNF-alpha -stimulated PMN-HSC adhesion and expression of VCAM-1 by suppressing the activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866874

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  [Sanggenon C induces apoptosis of prostate cancer PC3 cells by activating caspase 3 and caspase 9 pathways].

Authors:  Ping Zhou; Xiao-Xian Dong; Ping Tang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

2.  Sanggenon C decreases tumor cell viability associated with proteasome inhibition.

Authors:  Hongbiao Huang; Ningning Liu; Kai Zhao; Chenchen Zhu; Xiaoyu Lu; Shujue Li; Wen Lian; Ping Zhou; Xiaoxian Dong; Canguo Zhao; Haiping Guo; Change Zhang; Changshan Yang; Guanmei Wen; Li Lu; Xiaofen Li; Lixia Guan; Chunjiao Liu; Xuejun Wang; Qing Ping Dou; Jinbao Liu
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

3.  Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway.

Authors:  Lili Xiao; Yulei Gu; Lu Gao; Jiahong Shangguan; Yang Chen; Yanzhou Zhang; Ling Li
Journal:  Mol Med Rep       Date:  2017-08-18       Impact factor: 2.952

4.  Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway.

Authors:  Li-Dong Chen; Zhi-Hui Liu; Lian-Feng Zhang; Jian-Ning Yao; Chun-Feng Wang
Journal:  Oncol Rep       Date:  2017-08-22       Impact factor: 3.906

5.  Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model.

Authors:  Huijuan Wang; Tingting Feng; Donggui Guo; Min Zhang; Lin Chen; Ying Zhou
Journal:  Molecules       Date:  2018-09-13       Impact factor: 4.411

6.  Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy.

Authors:  Yang Gu; Lu Gao; Yu Chen; Zhuo Xu; Kun Yu; Dongying Zhang; Gang Zhang; Xiwen Zhang
Journal:  Mol Med Rep       Date:  2017-09-27       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.